CN103638485B - One treats the dyspeptic Chinese medicine composition of hepatopath - Google Patents

One treats the dyspeptic Chinese medicine composition of hepatopath Download PDF

Info

Publication number
CN103638485B
CN103638485B CN201310597932.4A CN201310597932A CN103638485B CN 103638485 B CN103638485 B CN 103638485B CN 201310597932 A CN201310597932 A CN 201310597932A CN 103638485 B CN103638485 B CN 103638485B
Authority
CN
China
Prior art keywords
parts
hepatopath
radix
rhizoma
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310597932.4A
Other languages
Chinese (zh)
Other versions
CN103638485A (en
Inventor
关纯
李谦
刘彩云
阎青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Municipal Hospital
Original Assignee
Qingdao Municipal Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Municipal Hospital filed Critical Qingdao Municipal Hospital
Priority to CN201310597932.4A priority Critical patent/CN103638485B/en
Publication of CN103638485A publication Critical patent/CN103638485A/en
Application granted granted Critical
Publication of CN103638485B publication Critical patent/CN103638485B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to one and treat the dyspeptic Chinese medicine composition of hepatopath, be made up of according to weight fraction following component: Rhizoma Atractylodis 30-40 part, Cortex Magnoliae Officinalis 30-40 part, Fructus Chaenomelis 30-40 part, Massa Medicata Fermentata 30-40 part, Rhizoma Cyperi 20-30 part, Radix Bupleuri 20-30 part, Flos Rosae Chinensis 20-30 part, Radix Linderae 20-30 part, Rhizoma Zingiberis Recens 10-20 part, Radix Gentianae 10-20 part.The dyspeptic Chinese medicine composition for the treatment of hepatopath of the present invention, reasonable recipe, in side, Rhizoma Atractylodis are drying damp and strengthening spleen, Cortex Magnoliae Officinalis circulation of qi promoting, dampness, removing food stagnancy, Fructus Chaenomelis removing dampness to restore normal function of the stomach, and Massa Medicata Fermentata helps digestion stomach function regulating, and four medicines are monarch drug altogether; Rhizoma Cyperi depressed liver-energy dispersing and QI regulating, menstruction regulating and pain relieving, Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI, Flos Rosae Chinensis promoting blood flow to regulate menstruation, resolving depression is subsided a swelling, Radix Linderae promoting the circulation of QI to relieve pain, four medicines are ministerial drug altogether, Rhizoma Zingiberis Recens relieving the exterior syndrome by diaphoresis, warming middle-JIAO to arrest vomiting, Radix Gentianae heat clearing and damp drying, removing fire from the liver, be adjuvant drug altogether, ten medicines share, and play effect of dampness, spleen invigorating, stomach function regulating, dispersing the stagnated live-QI to relieve the stagnation of QI altogether.Drug use of the present invention is convenient, Be very effective, effectively the disease for the treatment of hepatopath dyspepsia.

Description

One treats the dyspeptic Chinese medicine composition of hepatopath
Technical field
The present invention relates to Chinese medicine composition, particularly one treats the dyspeptic Chinese medicine composition of hepatopath.
Background technology
By the dysfunction of the incomplete caused aspect such as gastral motion, absorption, secretion, barrier, blood circulation of liver function, be referred to as liver property Gut peptides, a lot of hepatopath is usually that onset symptoms is gone to a doctor with dyspepsia; And the functional dyspepsia meeting Rome III diagnostic criteria is common especially clinically.Most dyspepsia patient has period of digestion and interdigestive phase dyskinesia, and gastric emptying is the leading indicator evaluating period of digestion function.
Hepatopath's dyspepsia main manifestations is side of body rib distension pain, uncomfortable in chestly heaves a deep sigh, spirit depressing, irascible temperament, decreased food intake of receiving is few, and tastelessness is dull, the vexed abdominal distention of gastral cavity, afternoon is very, deficiency of QI with disinclination to talk, extremity asthenia, shallow complexion, diarrhea or food indigested food, often increase the weight of because taking food the greasy and stodgy food of raw food.Pale tongue has indentation, and tongue is white, deep and stringy pulse.
Summary of the invention
For the defect existed in prior art, one is the object of the present invention is to provide to treat the dyspeptic Chinese medicine composition of hepatopath.
Technical scheme of the present invention is as follows:
One treats the dyspeptic Chinese medicine composition of hepatopath, is made up of according to weight fraction following component:
Rhizoma Atractylodis 30-40 part, Cortex Magnoliae Officinalis 30-40 part, Fructus Chaenomelis 30-40 part, Massa Medicata Fermentata 30-40 part, Rhizoma Cyperi 20-30 part, Radix Bupleuri 20-30 part, Flos Rosae Chinensis 20-30 part, Radix Linderae 20-30 part, Rhizoma Zingiberis Recens 10-20 part, Radix Gentianae 10-20 part.
The dyspeptic Chinese medicine composition for the treatment of hepatopath as above, is made up of according to weight fraction following component:
Rhizoma Atractylodis 35 parts, Cortex Magnoliae Officinalis 35 parts, Fructus Chaenomelis 35 parts, Massa Medicata Fermentata 35 parts, Rhizoma Cyperi 25 parts, Radix Bupleuri 25 parts, Flos Rosae Chinensis 25 parts, the Radix Linderae 25 parts, 15 parts, Rhizoma Zingiberis Recens, Radix Gentianae 15 parts.
The dyspeptic Chinese medicine composition for the treatment of hepatopath of the present invention, reasonable recipe, in side, Rhizoma Atractylodis are drying damp and strengthening spleen, Cortex Magnoliae Officinalis circulation of qi promoting, dampness, removing food stagnancy, Fructus Chaenomelis removing dampness to restore normal function of the stomach, and Massa Medicata Fermentata helps digestion stomach function regulating, and four medicines are monarch drug altogether; Rhizoma Cyperi depressed liver-energy dispersing and QI regulating, menstruction regulating and pain relieving, Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI, Flos Rosae Chinensis promoting blood flow to regulate menstruation, resolving depression is subsided a swelling, Radix Linderae promoting the circulation of QI to relieve pain, four medicines are ministerial drug altogether, Rhizoma Zingiberis Recens relieving the exterior syndrome by diaphoresis, warming middle-JIAO to arrest vomiting, Radix Gentianae heat clearing and damp drying, removing fire from the liver, be adjuvant drug altogether, ten medicines share, and play effect of dampness, spleen invigorating, stomach function regulating, dispersing the stagnated live-QI to relieve the stagnation of QI altogether.Drug use of the present invention is convenient, Be very effective, effectively the disease for the treatment of hepatopath dyspepsia.
Detailed description of the invention
Embodiment 1
One treats the dyspeptic Chinese medicine composition of hepatopath, is made up of (every part of 1g) according to weight fraction following component:
Rhizoma Atractylodis 30 parts, Cortex Magnoliae Officinalis 30 parts, Fructus Chaenomelis 30 parts, Massa Medicata Fermentata 30 parts, Rhizoma Cyperi 20 parts, Radix Bupleuri 20 parts, Flos Rosae Chinensis 20 parts, the Radix Linderae 20 parts, 10 parts, Rhizoma Zingiberis Recens, Radix Gentianae 10 parts.
Preparation method is as follows:
Take various component in above-mentioned composition according to quantity, join in 800 parts of water, boil 30 minutes, filter, abandon filtering residue, filtrate is concentrated into 200 parts.
Embodiment 2
The dyspeptic Chinese medicine composition for the treatment of hepatopath as above, is made up of (every part of 1g) according to weight fraction following component:
Rhizoma Atractylodis 35 parts, Cortex Magnoliae Officinalis 35 parts, Fructus Chaenomelis 35 parts, Massa Medicata Fermentata 35 parts, Rhizoma Cyperi 25 parts, Radix Bupleuri 25 parts, Flos Rosae Chinensis 25 parts, the Radix Linderae 25 parts, 15 parts, Rhizoma Zingiberis Recens, Radix Gentianae 15 parts.
Preparation method is with embodiment 1.
Embodiment 3
One treats the dyspeptic Chinese medicine composition of hepatopath, is made up of (every part of 1g) according to weight fraction following component:
Rhizoma Atractylodis 40 parts, Cortex Magnoliae Officinalis 40 parts, Fructus Chaenomelis 40 parts, Massa Medicata Fermentata 40 parts, Rhizoma Cyperi 30 parts, Radix Bupleuri 30 parts, Flos Rosae Chinensis 30 parts, the Radix Linderae 30 parts, 20 parts, Rhizoma Zingiberis Recens, Radix Gentianae 20 parts.
Preparation method is with embodiment 1.
Experimental example
Choose in hepatopath patient 80 example with indigestion symptom, take medicine prepared by the embodiment of the present invention 2, every day twice, each 50g 7 days was 1 course for the treatment of, and after taking for two courses for the treatment of continuously, 21 examples are cured, and effectively, 3 examples are invalid, total effective rate 96.3% for 56 examples.

Claims (2)

1. treat the dyspeptic Chinese medicine composition of hepatopath, it is characterized in that being made up of according to parts by weight following component:
Rhizoma Atractylodis 30-40 part, Cortex Magnoliae Officinalis 30-40 part, Fructus Chaenomelis 30-40 part, Massa Medicata Fermentata 30-40 part, Rhizoma Cyperi 20-30 part, Radix Bupleuri 20-30 part, Flos Rosae Chinensis 20-30 part, Radix Linderae 20-30 part, Rhizoma Zingiberis Recens 10-20 part, Radix Gentianae 10-20 part.
2. the dyspeptic Chinese medicine composition for the treatment of hepatopath according to claim 1, is characterized in that being made up of according to parts by weight following component:
Rhizoma Atractylodis 35 parts, Cortex Magnoliae Officinalis 35 parts, Fructus Chaenomelis 35 parts, Massa Medicata Fermentata 35 parts, Rhizoma Cyperi 25 parts, Radix Bupleuri 25 parts, Flos Rosae Chinensis 25 parts, the Radix Linderae 25 parts, 15 parts, Rhizoma Zingiberis Recens, Radix Gentianae 15 parts.
CN201310597932.4A 2013-11-22 2013-11-22 One treats the dyspeptic Chinese medicine composition of hepatopath Expired - Fee Related CN103638485B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310597932.4A CN103638485B (en) 2013-11-22 2013-11-22 One treats the dyspeptic Chinese medicine composition of hepatopath

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310597932.4A CN103638485B (en) 2013-11-22 2013-11-22 One treats the dyspeptic Chinese medicine composition of hepatopath

Publications (2)

Publication Number Publication Date
CN103638485A CN103638485A (en) 2014-03-19
CN103638485B true CN103638485B (en) 2015-11-18

Family

ID=50243857

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310597932.4A Expired - Fee Related CN103638485B (en) 2013-11-22 2013-11-22 One treats the dyspeptic Chinese medicine composition of hepatopath

Country Status (1)

Country Link
CN (1) CN103638485B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104154718A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Drying method of cortex magnoliae officinalis
CN104197646A (en) * 2014-08-25 2014-12-10 济南康众医药科技开发有限公司 Drying method of magnolia officinalis and application of magnolia officinalis product
CN104180611A (en) * 2014-08-25 2014-12-03 济南康众医药科技开发有限公司 Application of freeze-drying technology in mangnolia officinalis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中医药对功能性消化不良的整体研究;王晓敏 等;《甘肃科技》;20080623;第24卷(第12期);146-149 *
香乌汤治疗功能性消化不良62例;宋跃龙;《湖北中医杂志》;20040310;第26卷(第3期);45 *

Also Published As

Publication number Publication date
CN103638485A (en) 2014-03-19

Similar Documents

Publication Publication Date Title
CN101496887A (en) Medicament for treating acute hot, itching and wet severe type and chronic urticaria
CN103638485B (en) One treats the dyspeptic Chinese medicine composition of hepatopath
CN103055260A (en) Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof
CN104043009A (en) Medicine for treating stomach disease
CN103479947B (en) The preparation method of control constipation medicine
CN104147524A (en) Traditional Chinese medicine preparation for treating peptic ulcer
CN105250408B (en) A kind of Chinese medicine composition for treating an avian adenovirus infection
CN103893457A (en) Traditional Chinese medicine for treating ulcerative colitis
CN103550684B (en) A kind of Chinese medicine composition for the treatment of stomach carbuncle
CN104056171B (en) The Chinese medicine for the treatment of infantile malnutrition
CN102961696B (en) Chinese medicinal composition for treating diabetic nephropathy edema
CN105031580A (en) Traditional Chinese medicine formula for treating chronic non-atrophic gastritis, stomach ulcer and duodenal ulcer caused by deficiency cold of spleen and stomach
CN104667243A (en) Traditional Chinese medicament for treating ulcerative colitis
CN104971302A (en) Traditional Chinese medicine composition for treating biliary tract ascariasis
CN104306523A (en) Yao drug preparation for treating chronic pelvic inflammation and preparation method thereof
CN103599508B (en) One is used for the treatment of the uremic Chinese medicine composition of children's
CN106266774A (en) A kind of Traditional Chinese medicinal spray treating edema or edema disease
CN105288528A (en) Medicinal liquor for treating spleen-stomach disharmony
CN105797044A (en) Traditional Chinese medicinal composition for treating gastric ulcer
CN106581358A (en) Chinese medicine prescription for treating liver and stomach disharmony-type indigestion
CN105343806A (en) Traditional Chinese medicine preparation for treating gastritis and gastric ulcer
CN105194213A (en) Traditional Chinese medicine for treating chronic abdominal pain and diarrhea and preparation method thereof
CN105497392A (en) Traditional Chinese medicine formula for treating dyspepsia in the type of liver-stomach disharmony
CN105250805A (en) Traditional Chinese medicine for treating postpartum hypogalactia
CN105878918A (en) Medicine for treating urinary calculus

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151118

Termination date: 20161122